In a phase 1 study of stage 1 CRC, the consumption of 0.5 g or 1 g of resveratrol daily for eight days significantly reduced Ki-67-positive cancer cells [131], illustrating the potential neoadjuvant effect of this CRM. This evidence concerns the gene MKI67 and colorectal carcinoma.